Tag: Kalytera
Kalytera to Conclude Phase 2 Clinical Study and Initiate Phase 3 Study
SAN FRANCISCO and TEL AVIV, Israel – Kalytera Therapeutics, Inc. (TSX VENTURE: KLY and OTCQB: KALTF) (the "Company" or "Kalytera") today announced that interim...
Kalytera Announces Completion of Food Effect and QTc Study
SAN FRANCISCO and TEL AVIV, Israel – Kalytera Therapeutics, Inc. (TSX VENTURE: KLY and OTCQB: KALTF) (the "Company" or "Kalytera") today announced that it...
